Ultrasound Accuracy in Diagnosing Appendicitis in Obese Pediatric Patients

Bryan E Love1, Monica Camelo, Sarvenaz Nouri

  • 1Riverside University Health System, University of California, Riverside, California, USA.

The American Surgeon
|February 3, 2018
PubMed

Insights

Ultrasound is a reliable diagnostic tool for appendicitis in obese and overweight children, showing a 100% positive predictive value. This study confirms its utility in the growing pediatric population with obesity.

Area of Science:

  • Pediatric Radiology
  • Diagnostic Imaging
  • Abdominal Imaging

Background:

  • Ultrasound (US) is increasingly used for diagnosing appendicitis in children.
  • Its effectiveness in the growing population of obese pediatric patients requires further investigation.

Purpose of the Study:

  • To evaluate the diagnostic utility of ultrasound for appendicitis in pediatric patients stratified by body mass index (BMI) percentile.

Main Methods:

  • Retrospective review of pediatric patients (≤18 years) diagnosed with appendicitis from 2014-2016.
  • Patients were categorized by BMI percentile.
  • Ultrasound findings were compared with computed tomography (CT) results and clinical outcomes.

Main Results:

  • Of 231 patients, 99 underwent ultrasound; 54 were positive for appendicitis, and 43 were nondiagnostic.
  • Ultrasound demonstrated a 100% positive predictive value in overweight and obese children.
  • Nondiagnostic ultrasounds were followed by CT, with no significant BMI difference between CT-only and ultrasound groups.

Conclusions:

  • Ultrasound is a reliable imaging modality for diagnosing acute appendicitis in overweight and obese pediatric patients.
  • The findings support the continued use and improvement of ultrasound techniques in this demographic.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
251
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
2.6K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
300